New hope for teens with severe hay fever: xolair studied
NCT ID NCT04648930
First seen Mar 25, 2026 · Last updated May 15, 2026 · Updated 8 times
Summary
This study tested the drug Xolair in 50 teenagers aged 12 to 17 who had severe seasonal allergies that standard treatments couldn't control. The goal was to see if Xolair is safe and helps ease their symptoms. Doctors monitored for side effects and overall improvement.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC RHINITIS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.